Drug Overdose, Opioid-Related Disorders
Conditions
Brief summary
The U.S. is in the midst of an epidemic of opioid overdose deaths. The common use of opioids among persons living with HIV, along with their common use of benzodiazepines, has resulted in high rates of opioid overdose among this population. This study will test the implementation of evidence-based training, mentoring, technical support, and academic detailing to encourage HIV physicians to adopt evidence-based interventions to reduce overdose risk and treat opioid addiction.
Interventions
BEHAVIORALImplementation intervention
The implementation intervention includes peer-to-peer training, post-training outreach, proactive expert support, and assistance with addressing environmental barriers.
Sponsors
National Institute on Drug Abuse (NIDA)
The Miriam Hospital
Boston Medical Center
Rhode Island Hospital
Baystate Medical Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
Clinicians and staff of HIV practice sites that: * Receive Ryan White Funding; * Treat adults with HIV; * Have 3 or more prescribing clinicians; * Have an electronic medical record (EMR) with an electronic medication list.
Exclusion criteria
* Sites located in states with fewer than 500 Persons Living With HIV (PLWH) will be excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in naloxone prescribing behavior | baseline to 6 months | Number of clinicians that prescribe naloxone. This information will be collected from electronic medical record (EMR) data. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in perception about pharmacotherapy for opioid use disorder; 12-month | baseline to 12 months | Opinions About Medication Assisted Treatment (OAMAT) survey |
| Change in prescribing motivation; 6 months | baseline to 6 months | Change in Motivation Scale |
| Change in perception about pharmacotherapy for opioid use disorder; 6-month | baseline to 6 months | Opinions About Medication Assisted Treatment (OAMAT) survey |
| Change in prescriber training | baseline to 12 months | Number of prescribers that have completed buprenorphine training. |
| Change in buprenorphine prescribing behavior | baseline to 12 months | Prevalence of buprenorphine prescription. This information will be collected from EMR data. |
| Change in prescribing motivation; 12 months | baseline to 12 months | Change in Motivation Scale |
Countries
United States
Outcome results
None listed